Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Secondary Resistance”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Enrolling By InvitationNCT07583160
What this trial is testing

YS247 (Neoantigen-Pulsed DC Vaccine) for Metastatic Prostate Cancer

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer PatientsCastration-Resistant Prostate Cancer (CRPC)Prostate Neoplasms
Changhai Hospital 18
Not applicableStudy completedNCT02269982
What this trial is testing

Prospective CiRculating prOstate Cancer Predictors in HighEr Risk mCRPC studY

Who this might be right for
Prostate Cancer
Duke University 120
Early research (Phase 1)Looking for participantsNCT07277270
What this trial is testing

GSK5764227 in Combination With Standard of Care (SoC) or Other Agents in Participants With Advanced Solid Tumors

Who this might be right for
Neoplasms
GlaxoSmithKline 83
Testing effectiveness (Phase 2)Study completedNCT00880269
What this trial is testing

Efficacy and Safety of Panobinostat (LBH589) in Patients With Refractory de Novo or Secondary Acute Myelogenous Leukemia (AML)

Who this might be right for
Refractory LeukemiaAcute Myelogenous Leukemia
Novartis Pharmaceuticals 59
Testing effectiveness (Phase 2)Looking for participantsNCT06970119
What this trial is testing

A Multicenter, Open-label, Non-randomized Phase I/IIa Clinical Trial to Evaluate INR102 Injection in Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Yunhe Pharmaceutical (Tianjin) Co., Ltd 55
Testing effectiveness (Phase 2)Looking for participantsNCT07708194
What this trial is testing

Entinostat Plus Pyrotinib and Endocrine Therapy in Advanced Triple-Positive Breast Cancer After Trastuzumab Failure

Who this might be right for
Breast CancerHER2-positive Breast CancerHormone Receptor-Positive Breast Cancer+1 more
Tianjin Medical University Cancer Institute and Hospital 94
Testing effectiveness (Phase 2)Study completedNCT02159066
What this trial is testing

LGX818 and MEK162 in Combination With a Third Agent (BKM120, LEE011, BGJ398 or INC280) in Advanced BRAF Melanoma

Who this might be right for
Melanoma
Pfizer 158
Testing effectiveness (Phase 2)Ended earlyNCT00515112
What this trial is testing

Testosterone Replacement in Men With Non-Metastatic Castrate Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
University of Chicago 6
Testing effectiveness (Phase 2)Study completedNCT01039519
What this trial is testing

A Study Evaluating STA-9090 in Patients With Metastatic and/or Unresectable Gastrointestinal Stromal Tumor (GIST)

Who this might be right for
Gastrointestinal Stromal Tumor
Synta Pharmaceuticals Corp. 27
Testing effectiveness (Phase 2)Ended earlyNCT01267266
What this trial is testing

Saracatinib in Treating Patients With Prostate Cancer

Who this might be right for
Hormone-resistant Prostate CancerRecurrent Prostate CancerStage IV Prostate Cancer
National Cancer Institute (NCI) 31
Testing effectiveness (Phase 2)Active Not RecruitingNCT03813394
What this trial is testing

Bevacizumab and Pembrolizumab Combination in Platinum-resistant Recurrent/Metastatic NPC

Who this might be right for
Locally Recurrent CancerMetastatic Nasopharyngeal Cancer
National University Hospital, Singapore 48
Not applicableWithdrawnNCT01692483
What this trial is testing

Post-marketing Surveillance Study on the Safety and Effectiveness of Abiraterone Acetate Among Adult Filipino Male Patients With Advanced Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Prostate Neoplasms
Janssen Pharmaceutica
Not applicableStudy completedNCT02588001
What this trial is testing

Japanese Research for Patients With Non-metastatic Castration Resistant Prostate Cancer - Enzalutamide

Who this might be right for
Prostate Cancer
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan 60
Testing effectiveness (Phase 2)Study completedNCT03888612
What this trial is testing

Trial of ARV-110 in Patients With Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Prostate Cancer Metastatic
Arvinas Inc. 248
Not applicableNot Yet RecruitingNCT07264881
What this trial is testing

For Patients With Myocardial Infarction and Multiple Vessel: Testing if Ultrasound (UFR) Can Guide All Needed Treatment in One Procedure, Avoiding a Return Hospital Visit for a Second Operation.

Who this might be right for
Microvascular Obstruction (MVO)Multivessel Coronary Artery DiseaseACS (Acute Coronary Syndrome)+1 more
Beijing Anzhen Hospital 200
Not applicableUnknownNCT04177056
What this trial is testing

Stereotactic Body Radiotherapy for Osseous Low Alpha-Beta Resistant Metastases for Pain Relief

Who this might be right for
Bone MetastasesProstate CancerBreast Cancer+2 more
Hamilton Health Sciences Corporation 40
Early research (Phase 1)Study completedNCT00001302
What this trial is testing

A Phase I Study of Infusional Chemotherapy With the P-Glycoprotein Antagonist PSC 833

Who this might be right for
Breast CancerKidney NeoplasmLymphoma+2 more
National Cancer Institute (NCI) 80
Not applicableEnded earlyNCT02355275
What this trial is testing

Thera-Band® HEP for LBP Secondary Prevention

Who this might be right for
Low Back Pain
Sport and Spine Rehab Clinical Research Foundation 22
Large-scale testing (Phase 3)WithdrawnNCT02053311
What this trial is testing

Orteronel Maintenance Therapy in Patients With mCRPC Previously Treated With Novel Hormonal Agents

Who this might be right for
Prostate Cancer
Swiss Cancer Institute
Testing effectiveness (Phase 2)Ended earlyNCT04631601
What this trial is testing

Safety and Efficacy of Therapies for Metastatic Castration-resistant Prostate Cancer (mCRPC)

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Amgen 55
Next Page